The PDZD3 antibody is a research tool designed to detect and study the PDZ domain-containing protein 3 (PDZD3), a member of the PDZ protein family known for facilitating protein-protein interactions via their conserved PDZ domains. PDZD3. also called PDZK3 or PAPIN, is implicated in cellular processes such as signal transduction, membrane trafficking, and cell polarity regulation. Its structure includes multiple PDZ domains, enabling it to act as a scaffolding protein that organizes multi-protein complexes. Research suggests PDZD3 interacts with various partners, including receptors and transporters, potentially influencing pathways like Wnt/β-catenin signaling. Dysregulation of PDZD3 has been explored in cancers, where altered expression may correlate with tumor progression or metastasis.
PDZD3 antibodies are typically developed in hosts like rabbits or mice using immunogenic peptides or recombinant protein fragments. These antibodies enable techniques such as Western blotting, immunohistochemistry, and immunofluorescence to assess PDZD3 expression, localization, and interactions in cell lines or tissues. Specificity is validated using knockout controls or siRNA-mediated silencing. Studies utilizing PDZD3 antibodies aim to clarify its physiological roles, such as in epithelial cell function or neuronal development, and its pathological contributions to diseases. However, its full functional scope remains under investigation, highlighting the importance of reliable antibodies for ongoing research into PDZD3's molecular mechanisms and therapeutic potential.